From Casetext: Smarter Legal Research

Eli Lilly & Co. v. Teva Parenteral Medicines, Inc.

United States Court of Appeals for the Federal Circuit
Jul 25, 2014
567 F. App'x 967 (Fed. Cir. 2014)

Opinion

2014-1455

07-25-2014

ELI LILLY AND COMPANY, Plaintiff-Appellee, v. TEVA PARENTERAL MEDICINES, INC., APP PHARMACEUTICALS LLC, PLIVA HRVATSKA D.O.O., TEVA PHARMACEUTICALS USA, INC., AND BARR LABORATORIES, INC., Defendants-Appellants.


NOTE: This order is nonprecedential.

Appeal from the United States District Court for the Southern District of Indiana in No. 1:10-cv-01376-TWP-DKL, Judge Tonya Walton Pratt.

ON MOTION

Before REYNA, BRYSON, and TARANTO, Circuit Judges. BRYSON, Circuit Judge.

ORDER

The parties jointly move to remand this appeal so that they can litigate the issue of infringement in light of the United States Supreme Court's recent decision in Limelight Networks, Inc. v. Akamai Technologies, Inc., 134 S. Ct. 2111 (2014). In the district court, the parties jointly stipulated to induced infringement and proceeded to trial only on validity. As part of that stipulation, however, appellants reserved the right to litigate infringement if the Supreme Court granted the then-pending petition for writ of certiorari in Akamai and reversed or vacated this court's decision.

Accordingly,

IT IS ORDERED THAT:

(1) The motion is granted. This case is remanded for further proceedings consistent with this order.

(2) Each side shall bear its own costs.

FOR THE COURT

__________

Daniel E. O'Toole

Clerk of Court
s30


Summaries of

Eli Lilly & Co. v. Teva Parenteral Medicines, Inc.

United States Court of Appeals for the Federal Circuit
Jul 25, 2014
567 F. App'x 967 (Fed. Cir. 2014)
Case details for

Eli Lilly & Co. v. Teva Parenteral Medicines, Inc.

Case Details

Full title:ELI LILLY AND COMPANY, Plaintiff-Appellee, v. TEVA PARENTERAL MEDICINES…

Court:United States Court of Appeals for the Federal Circuit

Date published: Jul 25, 2014

Citations

567 F. App'x 967 (Fed. Cir. 2014)